Axonics Inc (AXNX)
67.28
+0.17
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
67.24
-0.04
(-0.06%)
After-Hours: 20:00
Axonics Cash from Financing (Quarterly): 0.248M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.248M |
| December 31, 2023 | 0.578M |
| September 30, 2023 | 0.878M |
| June 30, 2023 | -6.766M |
| March 31, 2023 | 1.93M |
| December 31, 2022 | 0.161M |
| September 30, 2022 | 131.88M |
| June 30, 2022 | 0.48M |
| March 31, 2022 | 1.444M |
| December 31, 2021 | 0.202M |
| September 30, 2021 | 1.523M |
| June 30, 2021 | 112.57M |
| March 31, 2021 | 56.22M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.055M |
| September 30, 2020 | 1.296M |
| June 30, 2020 | 141.50M |
| March 31, 2020 | 0.344M |
| December 31, 2019 | 110.49M |
| September 30, 2019 | 0.111M |
| June 30, 2019 | 0.308M |
| March 31, 2019 | 0.044M |
| December 31, 2018 | 135.58M |
| September 30, 2018 | 0.006M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 29.76M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-6.766M
Minimum
Jun 2023
141.50M
Maximum
Jun 2020
27.82M
Average
0.9665M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 1.569B |
| Cutera Inc | -0.232M |
| Stereotaxis Inc | 0.026M |
| Electromed Inc | 0.026M |
| Myomo Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.236M |
| Cash from Investing (Quarterly) | 138.23M |
| Free Cash Flow | -16.29M |
| Free Cash Flow Per Share (Quarterly) | -0.2414 |
| Free Cash Flow to Equity (Quarterly) | -12.30M |
| Free Cash Flow to Firm (Quarterly) | -12.30M |
| Free Cash Flow Yield | -0.49% |